Lensar (LNSR) Non-Current Debt (2019 - 2026)
Lensar's (LNSR) quarterly Non-Current Debt came in at $5.0 million in Q1 2026, down 75.25% on a QoQ basis from $20.2 million in Q4 2019.
Lensar (LNSR) Non-Current Debt (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 2 years of Non-Current Debt data on file, last reported at $5.0 million in Q1 2026.
- On a quarterly basis, Non-Current Debt changed N/A year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $5.0 million, a N/A change from a year earlier, with the FY2019 full-year figure at $20.2 million, changed N/A from the prior year.
- Non-Current Debt for Q1 2026 stood at $5.0 million, down from $20.2 million in the prior quarter.
- Over the last five years, Non-Current Debt for LNSR reached as high as $5.0 million in Q1 2026 and fell as low as $5.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2019 | 20.20 Mn |